Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
RUBYnanomed logo — Non-invasive monitoring of cancer progression

RUBYnanomed

Non-invasive monitoring of cancer progression

Founded 2018 Portugal Portugal 9 employees Seed Total: $2.60M Health Care

General Information

Company Name RUBYnanomed
Founded Year 2018
Location Portugal Portugal +1
Employees 9
Industries Health Care
Funding Stage Seed
Social

Get notified when RUBYnanomed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RUBYnanomed

Ruby Nanomed, a health care startup based in Portugal, has been making waves in the industry since its founding in 2018. With its slogan "Non-invasive monitoring of cancer progression," the company aims to address the significant global issue of cancer-related deaths, which reached 9.6 million in 2018. RUBYnanomed is focused on developing non-invasive monitoring tools for cancer progression, recognizing that 90% of cancer-related deaths are due to metastasis. Their flagship product, the RUBYchipTM, is a microfluidic device designed to isolate all types of circulating tumor cells (CTCs) from unprocessed whole blood, providing a precise snapshot of cancer. Currently, the company is actively involved in pre-clinical trials at 8 hospitals across Europe, targeting 5 different types of cancer. In August 2023, Ruby Nanomed secured significant backing through a Seed Round investment from The European Innovation Council, signifying confidence in the company's innovative approach and the potential impact of their technology. With cancer being a pressing global health concern, Ruby Nanomed's non-invasive monitoring solution holds promise for improving patient outcomes and reshaping the approach to cancer treatment and management.

Taxonomy: Metastases detection, Therapy monitoring, Patient stratification, Automated detection, Prognostic report, Sialyl-Tn, Circulating tumor cells, Muscle-invasive bladder cancer, Early detection, Cancer diagnostics, Innovative technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
24 Aug 2023
Grant •••••• 1
Investor
16 Jun 2021
Venture Round •••••• 2
Investor Investor
05 Mar 2021

RUBYnanomed Alternatives & Competitors

RUBYnanomed vs
Micromedic Technologies Ltd.
Micromedic Technologies Ltd. Israel

Micromedic Technologies specializes in the development and commercialization of innovative in vitro...

Post Ipo Equity
1 employees
Health Care
RUBYnanomed vs
Deep Lens (acquired by Paradigm)
Deep Lens (acquired by Paradigm) United States

Accelerating clinical trial matching in oncology

Series A
5 employees
AI, Health Care
RUBYnanomed vs
LIFEBRIDGE INNOVATIONS, PBC
LIFEBRIDGE INNOVATIONS, PBC United States

Future hope for stage 4 patients.

Equity Crowdfunding
2 employees
Health Care, Health and Wellness

FAQ About RUBYnanomed

Non-invasive monitoring of cancer progression
RUBYnanomed was founded in 2018.
RUBYnanomed is headquartered in Portugal.
RUBYnanomed operates in the following industries: Health Care.
RUBYnanomed has approximately 9 employees.
RUBYnanomed has completed 3 funding rounds, raising a total of $2.60M. The latest funding stage is Seed.
Top alternatives and competitors to RUBYnanomed include Micromedic Technologies Ltd., Deep Lens (acquired by Paradigm), LIFEBRIDGE INNOVATIONS, PBC, 诺辉健康 New Horizon Health Limited, Genelux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RUBYnanomed and Micromedic Technologies Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RUBYnanomed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy